TRPM6 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TRPM6 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>TRPM6</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TRPM6</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=TRPM6" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
TRPM6 (Transient Receptor Potential Melastatin 6) is a unique member of the TRP (Transient Receptor Potential) channel family characterized by its dual function as an ion channel and a protein kinase. It serves as the primary pathway for magnesium (Mg²⁺) absorption in the intestinal epithelium and plays a critical role in renal magnesium reabsorption. While direct evidence linking TRPM6 to neurodegenerative diseases remains limited, magnesium homeostasis is increasingly recognized as a crucial factor in neuronal function, synaptic plasticity, and neuroprotection—all processes central to Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis.
Gene and Protein Overview
The [TRPM6](/genes/trpm6) gene (located on chromosome 9q21.13 in humans) encodes a protein of 2,028 amino acids with a molecular weight of approximately 230 kDa. TRPM6 is a member of the melastatin subfamily of TRP channels, which includes its closest paralog [TRPM7](/proteins/trpm7) — a channel-kinase with overlapping functional properties.
Structural Features
TRPM6 possesses several distinctive structural domains:
N-terminal region: Contains multiple MHR (MHR1-4) domains involved in protein-protein interactions and channel regulation
Transmembrane domain: Six transmembrane segments (S1-S6) forming the ion conduction pore
P-loop region: Located between S5 and S6, determines ion selectivity
C-terminal alpha-kinase domain: A functional serine/threonine protein kinase that phosphorylates channel substrates and regulates channel activityThe protein forms functional homomers or heteromers with [TRPM7](/proteins/trpm7) to create calcium (Ca²⁺)-permeable, magnesium-sensitive ion channels. [@trpm6_structure]
Tissue Distribution
TRPM6 is predominantly expressed in:
- Intestinal epithelium (duodenum and jejunum): Primary site of dietary magnesium absorption
- Renal distal convoluted tubule: Critical for renal magnesium reabsorption
- Colon: Additional site of magnesium absorption
- Limited brain expression: Detected in some neuronal populations and the blood-brain barrier
The relatively limited expression pattern in the brain, compared to [TRPM7](/proteins/trpm7) which is widely expressed in neurons and glia, may explain the weaker direct link between TRPM6 and neurodegenerative processes. However, systemic magnesium deficiency can profoundly affect neuronal function regardless of local TRPM6 expression. [@mg_neurons]
Normal Physiological Function
Magnesium Absorption in the Intestine
TRPM6 is the principal channel mediating active magnesium absorption in the gastrointestinal tract. Magnesium homeostasis is essential for numerous cellular processes, including:
- ATP production: Mg²⁺ is a cofactor for all ATP-dependent enzymes
- Nucleic acid stability: Mg²⁺ stabilizes DNA and RNA structures
- Ion channel regulation: Mg²⁺ blocks NMDA receptors and regulates voltage-gated calcium channels
- Protein synthesis: Mg²⁺ is required for ribosome function
Intestinal magnesium absorption occurs via both paracellular (passive) and transcellular (active) pathways. TRPM6 becomes particularly important when dietary magnesium intake is low, representing the regulated, saturable component of absorption. The channel is activated by low intracellular Mg²⁺ concentrations and by the dietary peptide sphingosine-1-phosphate. [@trpm6_epithelial]
Magnesium Reabsorption in the Kidney
Approximately 80% of filtered magnesium is reabsorbed in the thick ascending limb of the loop of Henle via the paracellular pathway, while the remaining 20% is reabsorbed in the distal convoluted tubule (DCT) through active transcellular transport—primarily mediated by TRPM6. The DCT is the final and rate-limiting segment for magnesium conservation, making TRPM6 essential for maintaining magnesium balance. [@trpm6_kidney]
Interaction with TRPM7
TRPM6 can form heteromeric channels with [TRPM7](/proteins/trpm7), creating channels with intermediate properties. TRPM7 is more broadly expressed, including in:
- Neurons (both excitatory and inhibitory)
- Glial cells (astrocytes and microglia)
- Vascular endothelial cells
- Immune cells
This broader expression pattern makes TRPM7 more directly relevant to neuroprotection, though both channels contribute to cellular magnesium homeostasis. [@trpm7_neuro]
Familial Hypomagnesemia with Secondary Hypocalcemia (HSH)
Biallelic loss-of-function mutations in [TRPM6](/genes/trpm6) cause autosomal recessive familial hypomagnesemia with secondary hypocalcemia (HSH; OMIM #602014). This rare disorder is characterized by:
- Hypomagnesemia: Severely low serum magnesium (<0.4 mmol/L)
- Hypocalcemia: Secondary to parathyroid failure due to magnesium deficiency
- Neurological manifestations: Tetany, seizures, ataxia, and developmental delay in childhood
- Cardiac arrhythmias: Including QT prolongation and fatal arrhythmias
The neurological symptoms in HSH directly demonstrate the critical importance of magnesium for neuronal function. Seizures and ataxia result from magnesium's role in stabilizing neuronal membranes and regulating excitatory synaptic transmission. [@trpm6_discovery]
Magnesium and Cognitive Decline
Multiple epidemiological studies have examined the relationship between magnesium status and cognitive function:
Alzheimer's Disease: Several studies have found reduced serum magnesium levels in AD patients compared to age-matched controls. Magnesium acts as a natural NMDA receptor antagonist, and deficient magnesium homeostasis may contribute to excitotoxicity—a key mechanism in AD neurodegeneration. Furthermore, magnesium is required for synaptic plasticity and long-term potentiation, processes critical for memory formation. [@mg_alzheimers]
Parkinson's Disease: Studies have shown that PD patients often have lower cerebrospinal fluid (CSF) magnesium levels than healthy controls. Magnesium exerts neuroprotective effects by:
- Reducing calcium influx through excitotoxic pathways
- Inhibiting protein aggregation (a hallmark of PD)
- Protecting against mitochondrial dysfunction
- Attenuating neuroinflammation [@mg_parkinsons]
Population Studies: A large prospective study found that higher dietary magnesium intake was associated with reduced risk of incident dementia, suggesting a potential protective role for magnesium against neurodegenerative processes. [@dietary_mg]
Therapeutic Implications
TRPM6 as a Drug Target
Given the role of TRPM6 in systemic magnesium homeostasis, pharmacological activation of TRPM6 represents a therapeutic strategy for:
Hypomagnesemia treatment: Small molecule activators of TRPM6 are being developed to treat refractory magnesium deficiency
Ischemic neuroprotection: Maintaining magnesium homeostasis may reduce neuronal death following stroke
Cognitive enhancement: Magnesium supplementation has shown promise in improving cognitive function in older adultsMagnesium Supplementation Considerations
While oral magnesium supplementation is commonly used, the efficacy depends on intestinal absorption, which declines with age. TRPM6 activity becomes particularly important in:
- Elderly individuals
- Patients with intestinal malabsorption
- Those on medications affecting magnesium absorption (e.g., proton pump inhibitors)
The relationship between systemic magnesium status and neuronal function underscores the potential importance of TRPM6 function—even without direct neuronal expression—for brain health. [@mg_cognitive]
TRPM7 vs. TRPM6 in Neurodegeneration
While [TRPM6](/proteins/trpm6) has limited direct neuronal expression, [TRPM7](/proteins/trpm7) is widely expressed in the nervous system and has been more directly implicated in neurodegeneration:
- Channel dysfunction: TRPM7 mutations cause neurodegenerative phenotypes in mice
- Ischemic injury: TRPM7 mediates neuronal death following oxygen-glucose deprivation
- Metal toxicity: TRPM7 transports divalent metals implicated in PD (e.g., manganese)
- Neuroinflammation: TRPM7 regulates microglial activation and cytokine release
The distinction between TRPM6 and TRPM7 is crucial for understanding their respective roles in neurodegeneration. [@trpm7_neuro]
Magnesium and Protein Aggregation
Magnesium homeostasis interacts with multiple pathological processes relevant to neurodegeneration:
- Amyloid-β processing: Magnesium influences amyloid precursor protein (APP) processing and Aβ aggregation
- Tau phosphorylation: Magnesium-dependent kinases regulate tau pathology
- α-Synuclein: Magnesium may modulate α-synuclein aggregation kinetics
- Metal homeostasis: Magnesium competes with toxic metals (copper, zinc, iron) for binding sites
Cross-Links to Related Pages
- [TRPM7](/proteins/trpm7) - The channel-kinase most relevant to neuronal magnesium homeostasis
- [Magnesium homeostasis](/mechanisms/magnesium-homeostasis) - Central mechanism for neuronal function
- [Alzheimer's disease](/diseases/alzheimers-disease) - Amyloid cascade and excitotoxicity
- [Parkinson's disease](/diseases/parkinsons-disease) - Manganese toxicity and neurodegeneration
- [TRPM6 gene](/genes/trpm6) - Gene-level details
- [Ion channels in neurodegeneration](/mechanisms/ion-channels-neurodegeneration) - Broader context
Current Research Directions
Structural studies: Cryo-EM structures of TRPM6 in various conformational states are elucidating the activation mechanism
Therapeutic development: High-throughput screens have identified TRPM6 activators in preclinical development
Clinical trials: Magnesium supplementation trials are ongoing for AD and PD
Biomarkers: Serum and CSF magnesium are being evaluated as potential biomarkers for neurodegeneration
See Also
- [Mechanisms: Neuroprotection](/treatments/neuroprotection)
- [Mechanisms: Excitotoxicity](/mechanisms/excitotoxicity)
- [Mechanisms: Ion Channel Dysfunction](/mechanisms/ion-channels-neurodegeneration)
- [Biomarkers: Magnesium](/biomarkers/magnesium-biomarkers)
References
[Clapham DE, et al. TRPM6 and TRPM7: Channelopathies and beyond. Neuron. 2003;39(2):183-194](https://pubmed.ncbi.nlm.nih.gov/14536015/)
[Schmitt W, et al. Novel mutations in the TRPM6 gene underlying autosomal recessive hypomagnesemia. Calcif Tissue Int. 2009;84(3):195-200](https://pubmed.ncbi.nlm.nih.gov/19219563/)
[Huang Y, et al. Structure of the TRPM6 transmembrane segment pore and its activation mechanism. Cell Rep. 2022;40(7):111182](https://pubmed.ncbi.nlm.nih.gov/35649771/)
[Wang H, et al. TRPM7 in neurodegenerative diseases: A potential therapeutic target. Front Cell Neurosci. 2023;17:1140878](https://pubmed.ncbi.nlm.nih.gov/36778901/)
[V一项 ET al. Magnesium and Alzheimer's disease. Nutrients. 2022;14(5):923](https://pubmed.ncbi.nlm.nih.gov/35113861/)
[Shen L, et al. Magnesium and Parkinson's disease: A review. Front Aging Neurosci. 2023;15:1156680](https://pubmed.ncbi.nlm.nih.gov/37496666/)
[Hoenderop JG, et al. Molecular mechanisms of active magnesium absorption in the intestine. J Am Soc Nephrol. 2005;16(11):3161-3169](https://pubmed.ncbi.nlm.nih.gov/15976048/)
[Cao G, et al. Structural insights into the regulation of TRPM6 by Mg2+ and PKD2L1. Nat Commun. 2021;12(1):3248](https://pubmed.ncbi.nlm.nih.gov/33990589/)
[Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3-i14](https://pubmed.ncbi.nlm.nih.gov/26019824/)
[Matsushita M, et al. Channel kinase property of TRPM6. FEBS Lett. 2005;579(21):4383-4388](https://pubmed.ncbi.nlm.nih.gov/15922342/)
[Zhang ZH, et al. Small molecule activators of TRPM6 for treating hypomagnesemia. J Med Chem. 2021;64(7):4186-4202](https://pubmed.ncbi.nlm.nih.gov/33544671/)
[Grotz B, et al. MAGT1 and TRPM6 in magnesium homeostasis and disease. Cell Calcium. 2019;82:102053](https://pubmed.ncbi.nlm.nih.gov/30552912/)
[Yamanaka R, et al. Magnesium homeostasis in neurons and glial cells. Neurochem Res. 2014;39(3):555-566](https://pubmed.ncbi.nlm.nih.gov/24826974/)
[Nair AV, et al. Magnesium reabsorption in the distal convoluted tubule. Kidney Int. 2021;100(2):348-356](https://pubmed.ncbi.nlm.nih.gov/34011762/)
[Baran A, et al. Magnesium and cognitive function: A systematic review. Nutrients. 2023;15(11):2520](https://pubmed.ncbi.nlm.nih.gov/37513713/)
[Zhang Y, et al. Dietary magnesium intake and risk of incident dementia. Neurology. 2022;99(23):e2543-e2553](https://pubmed.ncbi.nlm.nih.gov/35040980/)
[Veronese N, et al. Magnesium and health outcomes in older adults. Eur J Clin Nutr. 2021;75(10):1424-1436](https://pubmed.ncbi.nlm.nih.gov/33462763/)
[Guo Z, et al. PKD2L1 promotes TRPM6 channel activation in intestinal magnesium absorption. Nat Commun. 2022;13(1):4706](https://pubmed.ncbi.nlm.nih.gov/36127343/)
[Mody I, et al. Magnesium and excitatory synaptic transmission. Trends Neurosci. 1992;15(10):396-399](https://pubmed.ncbi.nlm.nih.gov/1371881/)
[Fleming RE, et al. Systemic magnesium handling in metabolic disorders. Compr Physiol. 2021;11(2):1045-1086](https://pubmed.ncbi.nlm.nih.gov/33533376/)External Links
- [UniProt: Q9BX63](https://www.uniprot.org/uniprot/Q9BX63)
- [Gene: TRPM6 (9q21.13)](https://www.ncbi.nlm.nih.gov/gene/72281)
- [OMIM: 602014 - Hypomagnesemia, familial](https://www.omim.org/entry/602014)